Protocol: BPC-157 250 mcg daily SC + GHK-Cu topical or SC per dermatologic protocol
PubMed PMID: 40789979 Vukojevic et al
Regulatory Notice This compound has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any condition
All peptides should arrive in a lyophilised form, which is crucial for their stability during transport
Marker genes were identified using FindAllMarkers R package focusing on genes expressed by more than 10% of cells within a cluster and with a log fold change greater than 0.26
Hydroxocobalamin (Cyanokit , Meridian Medical Technologies, Columbia, MD, USA), a form of vitamin B12 conventionally used to treat cyanide poisoning, has recently been described as an off-label treatment for vasoplegic syndrome because it inhibits nitric oxide synthase and binds nitric oxide directly.1 An 82-yr-old man underwent open explantation of an abdominal aortic stent graft with replacement